Our Pricing

Buy Mounjaro or Ozempic Online - UK Prescription Service

When you buy Mounjaro or Ozempic online UK through Cured Pharmacy, you receive genuine UK-licensed medications with transparent upfront pricing from £135.00 a free clinical consultation completed in under 3 minutes, and discreet next-day delivery. Our UK-registered prescribers assess your suitability for tirzepatide or semaglutide-based treatments, ensuring you receive the most appropriate option for your weight management goals.

Mounjaro vs Ozempic: Understanding the Difference

Mounjaro (tirzepatide) and Ozempic (semaglutide) represent two distinct approaches to weight management, both licensed by the MHRA for UK use. Tirzepatide is the first dual GIP/GLP-1 receptor agonist, activating two metabolic pathways simultaneously, whilst semaglutide works as a single GLP-1 receptor agonist [1]. This dual mechanism gives Mounjaro a clinical advantage in head-to-head trials.

In the SURPASS-2 trial comparing tirzepatide directly against semaglutide 1mg, patients on the highest tirzepatide dose (15mg) achieved an average 12.4kg weight reduction compared to 6.2kg with semaglutide over 40 weeks [1]. Both medications require once-weekly subcutaneous injection and work by reducing appetite, slowing gastric emptying, and improving glycaemic control.

Your UK prescriber will determine which treatment suits your medical history, current medications, and weight loss targets. Factors including BMI, previous treatment response, and any contraindications influence this clinical decision, which cannot be made without a proper assessment.

How to Buy Mounjaro or Ozempic Online UK Safely

Purchasing prescription weight loss medications online requires careful verification of pharmacy credentials. Cured Pharmacy operates under GPhC registration 9012511, with superintendent pharmacist Tarun Kumar (GPhC 2233073) overseeing all clinical services. Every prescription must be issued by a UK-registered prescriber following a clinical assessment — there are no exceptions under UK pharmaceutical law.

Our online consultation takes under 3 minutes and covers your medical history, current medications, cardiovascular health, and weight management goals. The prescriber reviews your responses and may request additional information before approving treatment. This process ensures patient safety whilst maintaining the convenience of online access.

Once approved, your medication is dispensed from our UK pharmacy and delivered in 100% discreet packaging. We source only genuine UK-licensed medications — never grey-market imports or compounded alternatives that lack MHRA approval.

What the Online Assessment Involves

The clinical questionnaire covers your height, weight, BMI calculation, previous weight loss attempts, current medications (particularly diabetes treatments), cardiovascular history, thyroid conditions, and any history of pancreatitis or medullary thyroid carcinoma. These questions aren't administrative — they identify contraindications that would make GLP-1 treatment unsafe. Your prescriber may decline treatment if clinical risks outweigh benefits, prioritising patient safety over commercial considerations.

Mounjaro Dosing and Treatment Protocol

Mounjaro treatment follows a structured dose-escalation schedule designed to minimise gastrointestinal side effects whilst optimising efficacy. All patients start at 2.5mg once weekly for 4 weeks, increasing to 5mg for another 4 weeks [2]. Your prescriber then assesses tolerance and weight loss response before considering further increases to 7.5mg, 10mg, 12.5mg, or the maximum 15mg dose.

This gradual titration allows your body to adapt to tirzepatide's effects on gastric motility and appetite regulation. Rushing dose increases significantly raises the risk of nausea, vomiting, and treatment discontinuation. Clinical trials demonstrating Mounjaro's superior efficacy used this same escalation protocol [1][2].

Each KwikPen contains 4 pre-filled doses at your prescribed strength. You inject subcutaneously into your abdomen, thigh, or upper arm on the same day each week. Injection site rotation prevents lipohypertrophy and ensures consistent absorption.

Expected Timeline for Results

Most patients notice appetite reduction within the first week of treatment, though significant weight loss typically becomes apparent after 8-12 weeks once therapeutic doses are reached. In the SURMOUNT-1 trial, average weight reduction at 72 weeks was 15.0% with the 5mg dose, 19.5% with 10mg, and 20.9% with 15mg tirzepatide [2]. Individual results vary based on adherence, dietary modifications, physical activity, and metabolic factors. Weight loss is gradual and sustainable when combined with lifestyle changes, which remain essential components of any weight management programme.

Ozempic and Wegovy: Semaglutide for Weight Loss

Semaglutide is available in two formulations in the UK: Ozempic (licensed for type 2 diabetes) and Wegovy (licensed specifically for weight management). Both contain identical active ingredients but differ in maximum dosing — Ozempic reaches 1mg weekly whilst Wegovy escalates to 2.4mg weekly [3]. For weight loss purposes, Wegovy's higher dosing delivers superior results.

The STEP 1 trial demonstrated that semaglutide 2.4mg produced an average 14.9% body weight reduction over 68 weeks in adults without diabetes [3]. This represents substantial clinical benefit, though direct comparison trials show tirzepatide achieving greater weight reduction at equivalent timepoints [1].

Cured Pharmacy stocks Wegovy injection pens and the newly available Wegovy oral tablets, offering flexibility for patients who prefer tablet administration. Both formulations require dose escalation and ongoing prescriber monitoring.

Side Effects and Safety Considerations

Gastrointestinal side effects represent the most common adverse events with both tirzepatide and semaglutide. Nausea affects approximately 30-40% of patients during dose escalation, alongside potential vomiting, diarrhoea, constipation, and abdominal discomfort [1][3]. These effects typically diminish within 4-8 weeks as tolerance develops. Eating smaller meals, avoiding high-fat foods, and staying well-hydrated help manage symptoms.

Serious but rare risks include pancreatitis, gallbladder disease, acute kidney injury (usually secondary to dehydration from vomiting), and hypoglycaemia when combined with insulin or sulphonylureas. Both medications carry a boxed warning regarding thyroid C-cell tumours observed in rodent studies, though human relevance remains unclear [2][3]. Patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 cannot use these medications.

Your prescriber monitors treatment response and side effects through follow-up consultations. Report persistent vomiting, severe abdominal pain, visual changes, or signs of allergic reaction immediately. Most patients tolerate GLP-1 treatments well when dose escalation follows clinical protocols.

Who Cannot Use Mounjaro or Ozempic

Contraindications include pregnancy or breastfeeding, personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, previous severe hypersensitivity to tirzepatide or semaglutide, and diabetic ketoacidosis. Caution is required in patients with severe gastrointestinal disease, history of pancreatitis, severe renal impairment, or proliferative diabetic retinopathy. Age under 18 years represents an off-label use requiring specialist oversight. Your prescriber assesses these factors during consultation to ensure treatment safety.

Pricing and Prescription Process at Cured Pharmacy

Cured Pharmacy displays transparent upfront pricing before you begin consultation. Mounjaro starts from £135.00, with final cost determined by your prescribed dose following clinical assessment. We guarantee the lowest prices in the UK for genuine MHRA-licensed medications, never compromising on quality to reduce costs.

The prescription process begins with our free online consultation, completed in under 3 minutes. A UK-registered prescriber reviews your assessment within hours (often faster during business hours) and either approves treatment, requests additional information, or recommends alternative options if clinically appropriate. Approved prescriptions are dispensed the same day for next-day delivery across the UK.

Ongoing treatment requires periodic prescriber review to monitor efficacy, side effects, and any changes to your medical circumstances. These follow-up consultations ensure continued suitability and allow dose adjustments as needed. Weight loss medications work best as part of a comprehensive programme including dietary modification and increased physical activity — your prescriber provides guidance on these lifestyle components during consultations.

Scientific References

1. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
3. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to treatment, dietary modifications, and physical activity levels.